ES2054099T3 - Composicion estabilizada de interleucina-1-g(b). - Google Patents

Composicion estabilizada de interleucina-1-g(b).

Info

Publication number
ES2054099T3
ES2054099T3 ES89913181T ES89913181T ES2054099T3 ES 2054099 T3 ES2054099 T3 ES 2054099T3 ES 89913181 T ES89913181 T ES 89913181T ES 89913181 T ES89913181 T ES 89913181T ES 2054099 T3 ES2054099 T3 ES 2054099T3
Authority
ES
Spain
Prior art keywords
interleukin
stabilized composition
beta
interlenkin
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89913181T
Other languages
English (en)
Inventor
Yuji - Aza Nakasenaka Sugahara
Hirotsugu Kaise
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP63309264A external-priority patent/JPH0676332B2/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2054099T3 publication Critical patent/ES2054099T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

EL INVENTO PROPORCIONA UNA COMPOSICION ESTABILIZADA DEL INTERLENCKIN-1,(BETA), QUE CONTIENE INTERLENKIN 1,(BETA), QUE CONTIENE INTERLENKIN 1,(BETA) ACTIVADO, ALBUMINA DE SUERO HUMANO, Y/O UN AZUCAR Y UN SURFACTANTE.
ES89913181T 1988-12-06 1989-12-02 Composicion estabilizada de interleucina-1-g(b). Expired - Lifetime ES2054099T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63309264A JPH0676332B2 (ja) 1988-03-09 1988-12-06 インターロイキン‐１βの安定化組成物

Publications (1)

Publication Number Publication Date
ES2054099T3 true ES2054099T3 (es) 1994-08-01

Family

ID=17990905

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89913181T Expired - Lifetime ES2054099T3 (es) 1988-12-06 1989-12-02 Composicion estabilizada de interleucina-1-g(b).

Country Status (6)

Country Link
EP (1) EP0401379B1 (es)
KR (1) KR910700061A (es)
DE (1) DE68916237T2 (es)
DK (1) DK185690A (es)
ES (1) ES2054099T3 (es)
WO (1) WO1990006127A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616460A (en) * 1995-06-07 1997-04-01 Abbott Laboratories Buffer composition for reagents for immunoassay
US7351800B2 (en) * 2002-02-28 2008-04-01 Nipro Corporation Stabilized albumin preparations
WO2010105634A1 (en) * 2009-03-17 2010-09-23 United Technologies Ut Ag Use of interleukin-1 beta in cosmetic compositions and methods thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58206513A (ja) * 1982-05-28 1983-12-01 Eisai Co Ltd セクレチン吸着防止組成物および方法
EP0158487B1 (en) * 1984-04-09 1991-08-28 Takeda Chemical Industries, Ltd. Stable composition of interleukin-2
JPS61293926A (ja) * 1985-06-21 1986-12-24 Toray Ind Inc インタ−ロイキン−２組成物
JP2591615B2 (ja) * 1986-03-14 1997-03-19 大塚製薬株式会社 インターロイキン−１β誘導体及び医薬
CA1292686C (en) * 1986-10-27 1991-12-03 Ze'ev Shaked Pharmaceutical compositions of recombinant interleukin-2 and formulation process
US4816436A (en) * 1986-10-29 1989-03-28 Immunex Corporation Anti-arthritic use of interleukin-1 proteins
KR960008010B1 (ko) * 1988-07-29 1996-06-19 오오쓰까세이야꾸 가부시끼가이샤 IL-1α 유도체 및 혈소판 감소증 치료 약제
JP2554528B2 (ja) * 1988-09-19 1996-11-13 大塚製薬株式会社 副腎皮質刺激ホルモン分泌能検査薬
ZA902663B (en) * 1989-04-07 1991-12-24 Syntex Inc Interleukin-1 formulation
JP3221120B2 (ja) * 1992-12-25 2001-10-22 ソニー株式会社 復号装置

Also Published As

Publication number Publication date
DE68916237D1 (de) 1994-07-21
EP0401379A4 (en) 1992-05-06
EP0401379B1 (en) 1994-06-15
WO1990006127A1 (fr) 1990-06-14
KR910700061A (ko) 1991-03-13
DK185690D0 (da) 1990-08-03
DK185690A (da) 1990-10-05
EP0401379A1 (en) 1990-12-12
DE68916237T2 (de) 1994-11-10

Similar Documents

Publication Publication Date Title
MX9203176A (es) 1,2,4-triazolonas substituidas con fenoxietilo y composiciones farmaceuticas que las contienen.
PT83872A (de) Arzneimittel
DE3882899D1 (de) Mehrschicht-kollimator und diesen verwendende vorrichtung.
IT8720059A0 (it) Process per la preparazione di (2,2)-paraciclofano e suoi derivati.
NO881938D0 (no) Ortopedisk skinne.
NO841843L (no) Vippemekanisme for stolsete eller lignende.
TR26857A (tr) Insektisid ve/veya akarisid terkipler.
NO901430L (no) Fremgangsmaate til fremstilling av 4(3h)-pteridioner, og medikamenter inneholdende slike.
DE68915998D1 (de) Kolbenartiger elektromagnet.
MX9202935A (es) Derivados de 2,3-dihidro-1h-indeno y composicion farmaceutica que los contiene.
NO892352L (no) Ventilopphevingsmekanisme.
IT8820388A0 (it) Composizione oftalmologica.
ATE201996T1 (de) Hirudin enthaltende pharmazeutische zusammensetzungen
DE3864865D1 (de) Duftzusammensetzung.
FI910470A0 (fi) Regel.
EP0401379A4 (en) Stabilized composition of interleukin-1-g(b)
DE68907609D1 (de) Arzneimittelzusammensetzung.
DE69030105D1 (de) Zahnseide mit chemotherapeutischen wirkstoffen
IT1227787B (it) Oxo isoindolinil derivati otticamente attivi.
IT8622167A0 (it) Composizione perossidiche liquide.
MX9102369A (es) 2,6-alcoxifenil-alquilcetonas y composicion herbicida que las contiene.
DE68902056D1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
FI883008A0 (fi) 8 -acylaminoergolin, dess framstaellning och farmaceutiska kompositioner innehaollande detsamma.
MX9204164A (es) Composicion farmaceutica que comprende arndh.
DE3887237D1 (de) Arzneimittel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 401379

Country of ref document: ES